Abstract
The Asia-Pacific market for spinal implants and biomaterials represents a
significant portion of the world wide orthopedic market. The market is
comprised of four main segments: Spinal fusion implants, non-fusion implants,
spinal biomaterials, and vertebral compression fracture (VCF) treatment. This
report analyses these segments in Australia, China, Japan, South Korea and
Taiwan. In 2006, the Asia-Pacific market for spinal implants and biomaterials
was valued at over $500 million. The majority of this market value was
attributed to spinal fusion implants as depicted in Chart 1-1. Each market
segment will experience strong growth in the near future but growth of the
non-fusion and VCF markets will help drive double digit growth rates of the
total market. By 2013, the market value will reach over $1 billion.
View Cart
